Spots Global Cancer Trial Database for Anti-tumor Specific Immune Response in Head and Neck Cancers
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Anti-tumor Specific Immune Response in Head and Neck Cancers
Official Title: Anti-tumor Specific Immune Response in Head and Neck Cancers
Study ID: NCT02881918
Conditions
Interventions
Study Description
Brief Summary: The purpose is the description of anti-tumor immune responses in general and according to clinical stage and disease free survival (DFS: survival without recurrence (local or distant)) in patients with Head \& Neck Squamous Cell Carcinoma Secondary purposes are: * Study of relationship between anti-tumor immune response and qualitative (yes/no) and quantitative (number) presence of circulating tumor cells (CTCs); * Study of relationship between qualitative (yes/no) and quantitative (number) presence of CTCs and clinical stage as well as DFS * Study of relationship between anti-tumor immune response and clinical stage as well as DFS.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Service d'ORL - CHRU BESANCON, Besancon, , France
Service d'ORL - CHRU DIJON, Dijon, , France
Service d'ORL - CHRU REIMS, Reims, , France
Service d'ORL - CHRU STRASBOURG, Strasbourg, , France
Institut de Cancérologie Alexis Vautrin, Vandoeuvre les Nancy, , France
Service ORL - Institut Louis Mathieu - CHRU NANCY, Vandoeuvre les Nancy, , France
Contact Details
Name: Patrice GALLET
Affiliation: Service de ORL, Institut Louis Mathieu, CHRU de Nancy
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
